Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Two Genes Linked to Risk of Gallbladder Cancer

By LabMedica International staff writers
Posted on 14 Mar 2017
By performing a genome-wide scan (GWAS) of gallbladder cancer patients and hospital visitor controls, a team of researchers identified two genes that were associated with a small but definite risk of developing the disease.

Gallbladder cancer is highly lethal, with notable differences in incidence by geography and ethnic background. More...
A team comprising investigators from Johns Hopkins University, the [U.S.] National Cancer Institute and Tata Memorial Cancer Centre performed a genome-wide scan of gallbladder cancer cases and hospital visitor controls, both of Indian descent.

To carry out the study, the investigators collected blood samples from 1,042 patients who were treated in Mumbai between September 2010 and June 2015. They also collected blood samples during this time from 1,709 healthy volunteers matched by age, sex, and geographic origin with no known cancers who were visiting patients at the hospital. Thus, the discovery cohort comprised 1042 gallbladder cancer cases and 1709 controls while a replication cohort collected in 2015 and 2016 contained 428 gallbladder cancer cases and 420 controls.

The investigators examined three of the most significant single-nucleotide polymorphisms (SNPs) in the replication cohort and did a meta-analysis of the GWAS discovery and replication sets to get combined estimates of association.

Results revealed genome-wide significant associations for several markers in the chromosomal region 7q21.12 harboring both the ABCB1 (ATP-binding cassette sub-family B member 1) and ABCB4 (ATP binding cassette subfamily B member 4) genes. These genes are known to be involved in moving lipids through the liver, gallbladder, and bile ducts, and a previous study had associated ABCB4 with the formation of gallstones, a known risk factor for gallbladder cancer.

"Gallbladder cancer, like many other cancers and complex diseases, is likely to be associated with many genetic markers, each of which may have small effects, but in combination they can explain substantial variation in risk," said contributing author Dr. Nilanjan Chatterjee, professor of oncology and biostatistics at John Hopkins University. "Using the latest technologies to look at the causes – notably the genetic underpinnings – of this understudied disease just makes a lot of sense."

The study was published in the March 5, 2017, online edition of the journal The Lancet Oncology.


New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
Portable Electronic Pipette
Mini 96
New
Gold Member
Rapid AKI Test
Acute Kidney Injury (AKI) Array (4-plex)
New
Capillary Blood Collection Tube
IMPROMINI M3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.